Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · Real-Time Price · USD
21.03
-0.33 (-1.54%)
Dec 26, 2025, 4:00 PM EST - Market closed
Keros Therapeutics Employees
Keros Therapeutics had 169 employees as of December 31, 2024. The number of employees increased by 33 or 24.26% compared to the previous year.
Employees
169
Change (1Y)
33
Growth (1Y)
24.26%
Revenue / Employee
$1,459,870
Profits / Employee
$381,355
Market Cap
640.70M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 169 | 33 | 24.26% |
| Dec 31, 2023 | 136 | 31 | 29.52% |
| Dec 31, 2022 | 105 | 45 | 75.00% |
| Dec 31, 2021 | 60 | 25 | 71.43% |
| Dec 31, 2020 | 35 | 12 | 52.17% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
KROS News
- 5 weeks ago - Keros Therapeutics Announces Final Results of Tender Offer - GlobeNewsWire
- 5 weeks ago - Keros Therapeutics Announces Preliminary Results of Tender Offer - GlobeNewsWire
- 7 weeks ago - Keros Therapeutics Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 2 months ago - Keros Therapeutics Commences Issuer Tender Offer to Repurchase up to $194.4 Million Shares - GlobeNewsWire
- 2 months ago - Keros Therapeutics Announces Plan for Return of $375 Million in Excess Capital - GlobeNewsWire
- 3 months ago - Keros Therapeutics Presents Additional Clinical Data from its KER-065 Program at the American Society of Bone and Mineral Research 2025 Annual Meeting - GlobeNewsWire
- 4 months ago - Keros Therapeutics Announces Participation at Upcoming Healthcare Conferences - GlobeNewsWire
- 4 months ago - ADAR1 Sends Open Letter to Keros Board of Directors Urging the Board to Engage Constructively on Strategy, Capital Allocation and Board Refreshment - PRNewsWire